Considering some fake news that has been published in regards to the comparison study I thought it a good idea to look into it a bit more. The study that I am looking at has a link attached to the announcement (1)
Some really tragic data hear
Out of 455 ventilated critical ill just 16 discharged, MSBs 12 patients could be in this group leaving just 9
245 were still on ventilation unfortunately 162 go to the hospice or died group ...36% Now I know this is not 88% how ever as time goes on this % will unfortunately grow.
This study has been reported in the media with Various head line results. We will be hearing a lot more about this in the near future.
The outcomes of the 12 patients are outstanding. Make no mistake. Good luck all.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-809
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |